The Infectious Disease Working Group
Name |
Title |
Institute |
David Alland |
Interim Director, Center for Emerging and Re-Emerging Pathogens |
University of Medicine and Dentistry of New Jersey |
Leigh Anderson |
Founder and CEO |
Plasma Proteomics Institute |
Martin Blaser |
Frederick H. King Professor of Internal Medicine and Chairman of the Department of Medicine; Professor of Microbiology |
NYU Langone Medical Center |
Roger Brent |
President and Research Director |
The Molecular Sciences Institute |
Gail Cassell |
Vice President for Scientific Affairs |
Eli Lilly and Company |
John Dunn |
Member of the Brookhaven Council |
Brookhaven National Laboratory |
James Galagan |
Associate Director of Microbial Genome Analysis |
Broad Institute |
David Gelfand |
||
Michael Gottlieb |
Associate Director for Science |
The Foundation for National Institutes of Health |
Roderick Jensen |
Director of Core Laboratory Facility |
Virginia Bioinformatics Institute at Virginia Tech |
Michelle Momany |
Associate Professor, Department of Plant Biology |
University of Georgia |
Gabriele Neumann |
Associate Scientist, School of Veterinary Medicine |
University of Wisconsin – Madison |
Robert Quivey |
Professor, Department of Microbiology and Immunology |
University of Rochester Medical Center |
Eric Rubin |
Professor, Department of Immunology and Infectious Diseases |
Harvard School of Public Health |
Brendan Wren |
Professor, London School of Hygiene and Tropical Medicine |
London University |